| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.19 |
2e-05 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.18 |
9e-05 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |